Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001628280-25-014629
Filing Date
2025-03-25
Accepted
2025-03-25 10:35:29
Documents
18
Period of Report
2023-12-30

Document Format Files

Seq Description Document Type Size
1 10-K/A alts-20231230.htm   iXBRL 10-K/A 85536
2 EX-31.1 jan-20231230xex3111.htm EX-31.1 10267
3 EX-31.2 jan-20231230xex3121.htm EX-31.2 10239
4 EX-32.1 jan-20231230xex3211.htm EX-32.1 5905
5 EX-32.2 jan-20231230xex3221.htm EX-32.2 5919
  Complete submission text file 0001628280-25-014629.txt   329171

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alts-20231230.xsd EX-101.SCH 2416
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alts-20231230_lab.xml EX-101.LAB 35732
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alts-20231230_pre.xml EX-101.PRE 20954
21 EXTRACTED XBRL INSTANCE DOCUMENT alts-20231230_htm.xml XML 4860
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
ALT5 Sigma Corp (Filer) CIK: 0000862861 (see all company filings)

EIN.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-19621 | Film No.: 25766286
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)